Literature DB >> 19254245

High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients.

Amy C Wilson1, Larry A Greenbaum, Gina M Barletta, Deepa Chand, Jen-Jar Lin, Hiren P Patel, Mark Mitsnefes.   

Abstract

UNLABELLED: The goal of this study was to estimate prevalence of the metabolic syndrome and its association with cardiac abnormalities in children with kidney transplant. A multi-center retrospective review of demographic, clinical, laboratory, and echocardiographic parameters at time of and at one-yr post-transplant was conducted in 234 pediatric recipients between 2000 and 2006. Eighty-eight patients (37.6%) met criteria for metabolic syndrome. Among 55 overweight patients, 40% had metabolic syndrome. Among 51 obese patients, 74.5% had metabolic syndrome. A total of 181 (71.0%) patients had complete data at both time points: prevalence of metabolic syndrome at time of transplant was 18.8%, compared with 37.0% at one-yr post-transplant (p < 0.0001). Among 147 patients without metabolic syndrome at time of transplant, 41 (27.9%) had developed metabolic syndrome by one-yr post-transplant. A total of patients from four centers had routine echocardiogram at one-yr post-transplant. LVH was significantly more common in those with metabolic syndrome (55%) than in those without (32%) (OR 2.6, 95% CI 1.2-5.9). IN
CONCLUSION: metabolic syndrome is common at time of pediatric kidney transplant, and prevalence rises sharply at one-yr post-transplant. The presence of metabolic syndrome is strongly associated with LVH in these patients. (c) 2009 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2009        PMID: 19254245     DOI: 10.1111/j.1399-3046.2009.01141.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  29 in total

Review 1.  Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.

Authors:  Wacharee Seeherunvong; Myles Wolf
Journal:  Pediatr Transplant       Date:  2010-10-08

Review 2.  Paediatric obesity and renal transplantation: current challenges and solutions.

Authors:  John D Terrace; Gabriel C Oniscu
Journal:  Pediatr Nephrol       Date:  2015-05-28       Impact factor: 3.714

3.  Cardiorespiratory fitness is a marker of cardiovascular health in renal transplanted children.

Authors:  Trine Tangeraas; Karsten Midtvedt; Per Morten Fredriksen; Milada Cvancarova; Lars Mørkrid; Anna Bjerre
Journal:  Pediatr Nephrol       Date:  2010-07-30       Impact factor: 3.714

Review 4.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

Review 5.  A systems-based approach to managing blood pressure in children following kidney transplantation.

Authors:  David K Hooper; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2015-10-19       Impact factor: 3.714

6.  Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease.

Authors:  Amy C Wilson; Michael F Schneider; Christopher Cox; Larry A Greenbaum; Jeffrey Saland; Colin T White; Susan Furth; Bradley A Warady; Mark M Mitsnefes
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

Review 7.  Adherence in pediatric kidney transplant recipients: solutions for the system.

Authors:  Elizabeth A Steinberg; Mary Moss; Cindy L Buchanan; Jens Goebel
Journal:  Pediatr Nephrol       Date:  2017-03-27       Impact factor: 3.714

Review 8.  Long-Term Outcomes of Kidney Transplantation in Children.

Authors:  Pamela D Winterberg; Rouba Garro
Journal:  Pediatr Clin North Am       Date:  2019-02       Impact factor: 3.278

Review 9.  Long-term effects of paediatric kidney transplantation.

Authors:  Christer Holmberg; Hannu Jalanko
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

10.  Reliable individualized monitoring improves cholesterol control in kidney transplant recipients.

Authors:  David K Hooper; Cassie L Kirby; Peter A Margolis; Jens Goebel
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.